# Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%

> **NCT05765487** · PHASE1 · COMPLETED · sponsor: **Daré Bioscience, Inc.** · enrollment: 13 (actual)

## Conditions studied

- Sexual Arousal Disorder

## Interventions

- **DRUG:** Sildenafil
- **DRUG:** Vehicle
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05765487
- **Lead sponsor:** Daré Bioscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-13
- **Primary completion:** 2024-01-26
- **Final completion:** 2024-10-21
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05765487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05765487, "Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05765487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*